Effects of adapalene-benzoyl peroxide combination gel in treatment or maintenance therapy of moderate or severe acne vulgaris: A meta-analysis

Annals of Dermatology

Volumn 26, Issue 1, 2014, Pages 43-52

  Zhou, Rongying ^a   Jiang, Xian ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acne vulgaris; Adapalene; Benzoyl peroxide; Meta analysis

Indexed keywords

EID: 84901793649     PISSN: 10139087     EISSN: 20053894     Source Type: Journal    
DOI: 10.5021/ad.2014.26.1.43     Document Type: Article

References (24)

1. Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004;14:4-12.
2. Gollnick HP, Finlay AY, Shear N; Global Alliance to Improve Outcomes in Acne. Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008;9:279-284.
3. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003;49(3 Suppl.):S200-S210.
4. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al; Global Alliance to Improve Outcomes in Acne. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003;49(1 Suppl.):S1-S37.
5. Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al; Adapalene-BPO Study Group. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double- blind, controlled study. J Am Acad Dermatol 2007;57: 791-799.
6. Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, et al; Adapalene-BPO Study Group. Adapalene- benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: A transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 2009;161:1180-1189.
7. Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, et al; Adapalene-BPO Study Group. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis 2009;84:110-116.
8. Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol 2007;6:899-905.
9. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology 1998;196:119-125.
10. Michel S, Jomard A, Démarchez M. Pharmacology of adapalene. Br J Dermatol 1998;139 Suppl 52:3-7.
11. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997;36:S96-S103.
12. Bikowski JB. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination. J Drugs Dermatol 2005;4:164-171.
13. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol 1998;139 Suppl 52:8-11.
14. Poulin Y, Sanchez NP, Bucko A, Fowler J, Jarratt M, Kempers S, et al. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol 2011;164:1376-1382.
15. Gold LS, Cruz A, Eichenfield L, Tan J, Jorizzo J, Kerrouche N, et al. Effective and safe combination therapy for severe acne vulgaris: A randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Cutis 2010;85:94-104.
16. Dréno B, Kaufmann R, Talarico S, Torres Lozada V, Rodríguez- Castellanos MA, Gómez-Flores M, et al. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: A multicentre, randomized, double-blind controlled study. Br J Dermatol 2011;165:383-390.
17. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.0.2 [Internet]. London: The Cochrane Collaboration. 2008 [updated September 2009]. Available via DIALOG from: http://www. cochranehandbook.org.
18. Loesche C, Pernin C, Poncet M. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy. Eur J Dermatol 2008;18:524-526.
19. Andres P, Pernin C, Poncet M. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: A randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants. Cutis 2008;81:278-284.
20. Eichenfield LE, Jorizzo JL, Dirschka T, Taub AF, Lynde C, Graeber M, et al. Treatment of 2, 453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety. J Drugs Dermatol 2010;9:1395-1401.
21. Feldman SR, Tan J, Poulin Y, Dirschka T, Kerrouche N, Manna V. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am Acad Dermatol 2011;64:1085-1091.
22. Tan J, Gollnick HP, Loesche C, Ma YM, Gold LS. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients. J Dermatolog Treat 2011;22:197-205.
23. Tan J, Stein Gold L, Schlessinger J, Brodell R, Jones T, Cruz A, et al. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris. J Drugs Dermatol 2012;11:174-180.
24. Brodell RT, Schlosser BJ, Rafal E, Toth D, Tyring S, Wertheimer A, et al. A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne. J Dermatolog Treat 2012;23:26-34.